{"disease":{"id":"control-arm-in-phase-3-trial-for-rosuvastatin-20mg-hyperlipidemia-cardiovascular-risk-reduction.md","name":"control arm in phase 3 trial for rosuvastatin 20mg hyperlipidemia cardiovascular risk reduction.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}